D
ARKG icon

Diversified’s ARK Genomic Revolution ETF ARKG Stock Holding History

Diversified’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,321
Closed -$241K – 156
2022
Q3 		$241K Sell
7,321
-3,789
-34% -$139K 0.12% 103
2022
Q2 		$350K Sell
11,110
-3,487
-24% -$122K 0.15% 70
2022
Q1 		$670K Sell
14,597
-3,121
-18% -$149K 0.27% 57
2021
Q4 		$1.08M Sell
17,718
-1,445
-8% -$99.9K 0.46% 43
2021
Q3 		$1.43M Sell
19,163
-4,076
-18% -$342K 0.76% 32
2021
Q2 		$2.15M Sell
23,239
-6,937
-23% -$590K 1.2% 20
2021
Q1 		$2.68M Buy
30,176
+6,331
+27% +$628K 2.06% 15
2020
Q4 		$1.52M Buy
+23,845
New +$1.9M 1.29% 22

Other funds holding ARKG

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Diversified's ARKG Position: Q4 2022 in Review

Diversified sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 7,321 shares — an estimated $241K sold.

Diversified first reported a position in ARKG in Q4 2020 and held it in 8 quarters. The position peaked at $2.68M in Q1 2021. 319 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

  • Diversified reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
  • Diversified sold 7,321 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $241K.
  • Diversified first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 8 quarters.
  • Diversified's ARK Genomic Revolution ETF position peaked at $2.68M in Q1 2021.
  • 319 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Diversified's 13F filing for Q4 2022, filed 13 Feb 2023.